Aurélie Cabannes-Hamy

8PUBLICATIONS
40CO-AUTHORS
Haematological tumoursMolecular targetsAdolescent healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 29, 2025
BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.

Aurélie Cabannes-Hamy, Rayan Kabirian, Floriane Jochum

|Feb 20, 2025
Surface pTα expression predicts LCK activation and preclinical synergy of LCK and JAK coinhibition in adult T-ALL.

Lucien Courtois, Antoine Pinton, Aurélie Cabannes-Hamy

|Jan 05, 2025
Should adolescents and young adults with Hodgkin lymphoma be treated as children or adults?

Lucille Lew-Derivry, Florian Chevillon, Pauline Brice

|Oct 27, 2023
PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax.

Antoine Pinton, Lucien Courtois, Charlotte Doublet

|Apr 06, 2023
IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition.

Lucien Courtois, Aurélie Cabannes-Hamy, Rathana Kim

|May 20, 2020
Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemia.

Charlotte Calvo, Aurélie Cabannes-Hamy, Dalila Adjaoud

Pageof 2

Frequent Collaborators

4 joint publications

Philippe Rousselot

3 joint publications

Lucien Courtois

3 joint publications

Charlotte Smith

3 joint publications

Mathieu Simonin